Jeff Lynch
Senior Executive Oncology Specialist @Johnson & Johnson Innovative Medicine
Signup · Get unlimited contacts
WORK HISTORY
Senior Executive Oncology Specialist @Johnson & Johnson Innovative Medicine
Specialties: Multiple Myeloma, Chronic Lymphocytic Leukemia, Prostate Cancer, Ovarian Cancer, Mantle Cell Lymphoma, Erythropoiesis-Stimulating Agents, Urology, Nephrology. Product launch experience: 2015 Darzalex, 2013, 2014, 2015, 2016 Imbruvica; 2011 Zytiga and 1996 Serostim Regional and District Manager areas covered: New York Metro, New Jersey, Delaware and ConnecticutSales Geographic territories covered include NYC, Long Island, Connecticut and Westchester County and New Jersey Specialty Pharmacy experience, Contracting and reimbursement in oncology, oral oncolytics with specialty pharmacies, ESA stimulating injectables, chemotherapy
SKILLS
ABOUT JEFF LYNCH
Janssen Oncology sales professional focusing on Leukemia & Lymphoma, Myeloma & mCRPC…
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.